Disease Info Card

Hypobetalipoproteinemias

Information about Hypobetalipoproteinemias: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hypobetalipoproteinemias

Most recent studies have shown that Hypobetalipoproteinemias shares some biological mechanisms with abetalipoproteinemia, acanthocytosis, atherosclerosis, chylomicron-retention-disease, coronary-heart-disease, familial-hypobetalipoproteinemia, fatty-liver, heart-diseases, hepatoblastoma, hypercholesterolemia, hyperlipidemia, hyperlipoproteinemias, hypocholesterolemia, hypolipoproteinemias, liver-diseases, malabsorption-syndrome, steatohepatitis, steatosis, tangier-disease, vitamin-e-deficiency.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hypobetalipoproteinemias, and have been seen in publications frequently: Aging, Bone Maturation, Cholesterol Esterification, Cholesterol Homeostasis, Chylomicron Assembly, Endocytosis, Excretion, Fatty Acid Transport, Intestinal Absorption, Lipid Transport, Localization, Mrna Splicing, Mrna Transcription, Pathogenesis, Pigmentation, Proteolysis, Reflex, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Hypobetalipoproteinemias, such as ANGPTL3, APOA1, APOB, APOE, CD55, INS, LDLR, LPA, LPL, MT1B, MTTP, PCSK9, SAR1B, SEPSECS, TG. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.